Last: | $0.3138 |
---|---|
Change Percent: | 0.0% |
Open: | $0.3702 |
Close: | $0.3138 |
High: | $0.4 |
Low: | $0.3138 |
Volume: | 4,123,861 |
Last Trade Date Time: | 04/17/2025 04:00:02 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.3138 | $0.3702 | $0.3138 | $0.4 | $0.3138 | 4,123,861 | 04-18-2025 |
$0.3138 | $0.3702 | $0.3138 | $0.4 | $0.3138 | 4,123,861 | 04-17-2025 |
$0.3816 | $0.3259 | $0.3816 | $0.419 | $0.316 | 930,605 | 04-16-2025 |
$0.336 | $0.331 | $0.336 | $0.38 | $0.325 | 580,825 | 04-15-2025 |
$0.349 | $0.32 | $0.349 | $0.355 | $0.3 | 311,574 | 04-14-2025 |
$0.324 | $0.286 | $0.324 | $0.325 | $0.286 | 580,157 | 04-11-2025 |
$0.2608 | $0.33 | $0.2608 | $0.349 | $0.2608 | 531,818 | 04-10-2025 |
$0.3341 | $0.3 | $0.3341 | $0.341 | $0.2828 | 1,102,449 | 04-09-2025 |
$0.325 | $0.3 | $0.325 | $0.34 | $0.27 | 312,102 | 04-08-2025 |
$0.2908 | $0.31 | $0.2908 | $0.3289 | $0.2612 | 525,889 | 04-07-2025 |
$0.29 | $0.34 | $0.29 | $0.34 | $0.252 | 559,055 | 04-04-2025 |
$0.3186 | $0.33 | $0.3186 | $0.34 | $0.3 | 346,154 | 04-03-2025 |
$0.3325 | $0.3449 | $0.3325 | $0.36 | $0.31 | 435,590 | 04-02-2025 |
$0.34 | $0.34 | $0.34 | $0.36 | $0.31 | 704,396 | 04-01-2025 |
$0.37 | $0.3101 | $0.37 | $0.37 | $0.3101 | 918,753 | 03-31-2025 |
$0.4313 | $0.4137 | $0.4313 | $0.451 | $0.4137 | 140,349 | 03-28-2025 |
$0.4265 | $0.4364 | $0.4265 | $0.4675 | $0.4169 | 124,009 | 03-27-2025 |
$0.44 | $0.46 | $0.44 | $0.4999 | $0.44 | 42,423 | 03-26-2025 |
$0.47 | $0.49 | $0.47 | $0.49 | $0.453 | 60,855 | 03-25-2025 |
$0.4899 | $0.49 | $0.4899 | $0.52 | $0.47 | 81,203 | 03-24-2025 |
News, Short Squeeze, Breakout and More Instantly...
Enzo Biochem Inc. Company Name:
ENZ Stock Symbol:
NYSE Market:
0.0% G/L:
$0.3138 Last:
4,123,861 Volume:
$0.3702 Open:
$0.3138 Close:
Enzo Biochem Inc. Website:
FARMINGDALE, N.Y., March 28, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced its intention to voluntarily delist its common stock from The New York Stock Exchange (“NYSE”) and to have its common stock quot...
FARMINGDALE, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal second quarter ended January 31, 2025, with sequential quarter improvement in revenue, gross margin and opera...
Portage Biotech Inc. (PRTG) is expected to report for Q3 2025 Aimei Health Technology Co. Ltd (AFJK) is expected to report for quarter end 2024-12-31 Generation Bio Co. (GBIO) is expected to report $-0.28 for Q4 2024 TAT Technologies Ltd. (TATT) is expected to report for quarter end 2...